全国服务咨询热线:

18438616290

Products产品中心
首页 > 产品中心 > 生化试剂 > 小分子化合物 > abs47028306SB273005 205678-31-5

SB273005 205678-31-5

简要描述:SB273005 205678-31-5
SB273005 is a potent integrin inhibitor with Ki of 1.2 nM and 0.3 nM for αvβ3 receptor and αvβ5 receptor, respectively.

  • 产品型号:abs47028306
  • 厂商性质:生产厂家
  • 更新时间:2026-01-28
  • 访  问  量:888

详细介绍

品牌absinCAS205678-31-5
分子式C22H24F3N3O4纯度98%
分子量451.44货号abs47028306
规格5mg供货周期现货
主要用途is a potent integrin inhibitor应用领域化工,生物产业,农林牧渔,制药/生物制药,综合

SB273005 205678-31-5

产品描述
描述
SB273005 is a potent integrin inhibitor with Ki of 1.2 nM and 0.3 nM for αvβ3 receptor and αvβ5 receptor, respectively.
纯度
98%
储存/保存方法
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
基本信息
可溶性/溶解性
DMSO:90 mg/mL warmed (199.36 mM)
生物活性
靶点
αvβ5 receptor ,αvβ3 receptor
In vitro(体外研究)
In vitro, SB273005 inhibits human osteoclast-mediated bone resorption with IC50 of 11 nM. In blood containing MDA-MB-231 cells, a combination of SB273005 and lamifiban inhibits tumor cell adhesion to vascular extracellular matrix (ECM).
In vivo(体内研究)
In rat models of bone resorption and osteoporosis, SB273005 (30 mg/kg, p.o.) inhibits the parathyroid hormone-stimulated calcemic response, and inhibits bone loss. In rat with adjuvant-induced arthritis, SB273005 (60 mg/kg, p.o.) significantly reduces the symptoms of adjuvant-induced arthritis. SB273005 (1000 mg/kg/day, p.o.) causes acute, transient necrosis of vascular smooth muscle cell (VSMC) in aorta and renal arteries of mice. In pregnant mice, SB273005 reverses the reduction of Th1 cell-produced IL-2 levels and the increase of Th2 cell-derived IL-10 levels.
参考文献
参考文献
研究领域
研究领域
Signal TransductionCytoskeleton / ECMCytoskeleton
Drug DiscoverySmall Molecule DrugLead Compound Discovery
SB273005 205678-31-5温馨提示:本产品仅作科研实验使用,不支持临床等研究

产品咨询

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
爱必信(上海)生物科技有限公司
地址:上海市浦东新区新浩路58号申江科创园18栋
邮箱:lanwu@univ-bio.com
传真:
关注我们
欢迎您关注我们的微信公众号了解更多信息:
欢迎您关注我们的微信公众号
了解更多信息